Ruda M. Immunoactive agents in combined treating patients with diffuse toxic goitre.

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0400U000792

Thesis Registration Form

0400U000792.pdf

Applicant for

Specialization

  • 14.01.14 - Ендокринологія

28-03-2000

Specialized Academic Board

Д 26.558.01

STATE INSTITUTE "V.P. KOMISSARENKO INSTITUTE OF ENDOCRINOLOGY AND METABOLISM OF THE NATIONAL ACADEMY OF MEDICAL SCIENCE OF UKRAINE"

Essay

The patients with diffuse toxic goitre (DTG) were studied.The work aimed at basing the expediency of new methods in treatment of patients with DTG using immunoactive agents. Methods and tests : immunologic, clinical, biochemical, instrumental, microscope, spectrophotometer.Clinico-instrumental criteria for differentuated use of Immunoactive agents (thymalin, prednisolon, their combination and laser therapy) for complex treatment in patients with DTG were determined.Five immunologic groups of patients were chosen for the First time.Given complex of clinico- immunologic studies is applied in endocrinologic departments.The sphere of use: endocrinology.

Read more

Similar theses

0523U100041

Yuliya V. Buldygina

Graves' disease: pathogenetic aspects, clinico-morphological and immune factors, optimization of personalized treatment algorithms.

0521U102094

Cherska Mariia

Cardiocerebral disorders in patients with diabetes mellitus with cerebral atherosclerosis: features of relationships, factors of progression, diagnosis and ways of correction

0521U101828

Watseba Tamara Sergiyvna

Epidemiology of oncological diseases in patients with diabetes mellitus and the effect of antidiabetic medication on oncogenic markers.

0521U101330

Halyna P. Mykhalchyshyn

Pathophysiological mechanisms of the clinical progression variability and system of medical care for the patients with type 2 diabetes mellitus who also have non-alcoholic fatty liver disease.

0521U101295

Seliukova Nataliia Yuryevna

The reproductive system pathologies of offspring born to mothers with fetoplacental insufficiency: hormone depended mechanisms of developing and prophylaxis (experimental investigation).